Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpes Simplex, Genital”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00740584
What this trial is testing

Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

Who this might be right for
HIV InfectionsHSV-2 Genital Herpes
Starpharma Pty Ltd 12
Testing effectiveness (Phase 2)Study completedNCT02300142
What this trial is testing

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT00486200
What this trial is testing

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Who this might be right for
Herpes Genitalis
Astellas Pharma Inc 695
Early research (Phase 1)UnknownNCT05393440
What this trial is testing

First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Zhongnan Hospital 18
Testing effectiveness (Phase 2)Study completedNCT01047540
What this trial is testing

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

Who this might be right for
HSV-2
AiCuris Anti-infective Cures AG 156
Post-approval studies (Phase 4)Study completedNCT00219310
What this trial is testing

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

Who this might be right for
Recurrent Genital Herpes (RGH)
Novartis
Not applicableStudy completedNCT04950712
What this trial is testing

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Who this might be right for
Herpes Genitalis
GlaxoSmithKline 537
Not applicableStudy completedNCT01390805
What this trial is testing

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Who this might be right for
Genital Herpes
GlaxoSmithKline 462
Large-scale testing (Phase 3)Study completedNCT00262106
What this trial is testing

Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection

Who this might be right for
HIV InfectionsGonorrheaChlamydial Infections+1 more
Endo USA Inc., a Keenova Therapeutics Company 9,404
Early research (Phase 1)Study completedNCT00231049
What this trial is testing

Trial Evaluating Safety, Tolerability and Immune Response of AG-707

Who this might be right for
Genital Herpes
Agenus Inc. 35
Post-approval studies (Phase 4)Study completedNCT00477334
What this trial is testing

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

Who this might be right for
Genital Herpes
Novartis 463
Not applicableStudy completedNCT05500053
What this trial is testing

The Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

Who this might be right for
Genital HerpesPatient Engagement
Rational Vaccines Inc 68
Post-approval studies (Phase 4)Study completedNCT01346475
What this trial is testing

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Who this might be right for
Genital Herpes
University of Washington 50
Post-approval studies (Phase 4)Study completedNCT00116844
What this trial is testing

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Who this might be right for
Infections, Herpesviridae
GlaxoSmithKline 73
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Early research (Phase 1)Study completedNCT06698575
What this trial is testing

Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 103
Testing effectiveness (Phase 2)Study completedNCT00405821
What this trial is testing

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Who this might be right for
HIV InfectionsHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 440
Large-scale testing (Phase 3)Study completedNCT00076232
What this trial is testing

Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

Who this might be right for
HIV InfectionsHIV SeronegativityHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 3,682
Not applicableStudy completedNCT00002186
What this trial is testing

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals 400
Not applicableStudy completedNCT01460433
What this trial is testing

Problems With Immune Recovery in the Gut Tissue

Who this might be right for
Human Immunodeficiency Virus
University of Minnesota 21
Next Page